60 Degrees Pharmaceuticals, Inc.
SXTPW· Nasdaq
SXTPW60 Degrees Pharmaceuticals, Inc.
Filed Nov 20, 2023 · 10-Q · 51 days after period end · 0001213900-23-088610
| Metric | Q3 2023 | Q3 2022 |
|---|---|---|
| Revenue | $51.19K | $168.19K |
| Net Income | $4.18M | -$1.45M |
| EPS Diluted | $9.13 | -$0.61 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 20, 2023 · 51 d after period end
